BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2263810)

  • 1. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol.
    Herbst AL; Anderson D
    Semin Surg Oncol; 1990; 6(6):343-6. PubMed ID: 2263810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects in the human of diethylstilbestrol (DES) use during pregnancy.
    Herbst AL
    Princess Takamatsu Symp; 1987; 18():67-75. PubMed ID: 3506546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear-cell adenocarcinoma of the vagina and cervix in girls: analysis of 170 registry cases.
    Herbst AL; Robboy SJ; Scully RE; Poskanzer DC
    Am J Obstet Gynecol; 1974 Jul; 119(5):713-24. PubMed ID: 4857957
    [No Abstract]   [Full Text] [Related]  

  • 4. Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix.
    Herbst AL; Cole P; Colton T; Robboy SJ; Scully RE
    Am J Obstet Gynecol; 1977 May; 128(1):43-50. PubMed ID: 851158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update.
    Melnick S; Cole P; Anderson D; Herbst A
    N Engl J Med; 1987 Feb; 316(9):514-6. PubMed ID: 3807995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genital clear cell adenocarcinoma.
    Johnston GA; Jones HA
    Int Surg; 1983; 68(3):257-61. PubMed ID: 6662641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.
    Huo D; Anderson D; Palmer JR; Herbst AL
    Gynecol Oncol; 2017 Sep; 146(3):566-571. PubMed ID: 28689666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol.
    Horwitz RI; Viscoli CM; Merino M; Brennan TA; Flannery JT; Robboy SJ
    J Clin Epidemiol; 1988; 41(6):593-7. PubMed ID: 3385459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six years' experience with screening of a diethylstilbestrol-exposed population.
    Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
    Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
    Barclay DL
    J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic].
    van Dijck JA; Doorduijn Y; Bulten JH; Verloop J; Massuger LF; Kiemeney BA
    Ned Tijdschr Geneeskd; 2009; 153():A366. PubMed ID: 19857300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of adenosis and clear-cell adenocarcinoma of the genital tract in young females.
    Herbst AL; Scully RE; Robboy SJ
    J Reprod Med; 1975 Jul; 15(1):5-11. PubMed ID: 1151941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix.
    Herbst AL; Cole P; Norusis MJ; Welch WR; Scully RE
    Am J Obstet Gynecol; 1979 Dec; 135(7):876-86. PubMed ID: 507130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The current status of the DES-exposed population.
    Herbst AL
    Obstet Gynecol Annu; 1981; 10():267-78. PubMed ID: 7024873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks.
    Hanselaar A; van Loosbroek M; Schuurbiers O; Helmerhorst T; Bulten J; Bernhelm J
    Cancer; 1997 Jun; 79(11):2229-36. PubMed ID: 9179071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In utero exposure to DES. Evaluation and followup of 199 women.
    Fowler WC; Edelman DA
    Obstet Gynecol; 1978 Apr; 51(4):459-63. PubMed ID: 662229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States).
    Hatch EE; Herbst AL; Hoover RN; Noller KL; Adam E; Kaufman RH; Palmer JR; Titus-Ernstoff L; Hyer M; Hartge P; Robboy SJ
    Cancer Causes Control; 2001 Nov; 12(9):837-45. PubMed ID: 11714112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear-cell adenocarcinoma of the genital tract in young females. Registry report.
    Herbst AL; Kurman RJ; Scully RE; Poskanzer DC
    N Engl J Med; 1972 Dec; 287(25):1259-64. PubMed ID: 4636892
    [No Abstract]   [Full Text] [Related]  

  • 20. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.
    Camp EA; Prehn AW; Shen J; Herbst AL; Strohsnitter WC; Hobday CD; Robboy SJ; Adam E
    J Womens Health (Larchmt); 2015 Apr; 24(4):308-15. PubMed ID: 25768943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.